Prostate cancer, prostate hyperplasia, kidney cancer, renal vascular smooth muscle tumor
Conditions
Interventions
Case Group:None
Healthy control group:None
Sponsors
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Case Group 1.Adults (aged 18 or above), suspected or newly diagnosed or previously treated patients with urinary system disorders (including prostate, kidney, bladder tumors, inflammation or other disorders); 2. Willing and able to provide informed consent for the collection of prospective data (or provide existing consent for the use of retrospective data). Healthy and normal population Adults (aged 18 or above), without suffering from benign or malignant tumors; 2. Pass the physical examination and have no dysfunction of major organs; 3. Normal renal function and no proteinuria.
Exclusion criteria
Exclusion criteria: 1.Unable or unwilling to provide imaging or relevant clinical records; 2.Also participating in another research trial that does not allow sharing of data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostic Performance; | — |
Countries
China
Contacts
Public ContactXie Xin
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Outcome results
None listed